Metabolism of thalidomide by human liver microsome cytochrome CYP2C19 is required for its antimyeloma and antiangiogenic activities in vitro.
about
Metabolism of thalidomide by human liver microsome cytochrome CYP2C19 is required for its antimyeloma and antiangiogenic activities in vitro.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Metabolism of thalidomide by h ...... ngiogenic activities in vitro.
@en
Metabolism of thalidomide by h ...... ngiogenic activities in vitro.
@nl
type
label
Metabolism of thalidomide by h ...... ngiogenic activities in vitro.
@en
Metabolism of thalidomide by h ...... ngiogenic activities in vitro.
@nl
prefLabel
Metabolism of thalidomide by h ...... ngiogenic activities in vitro.
@en
Metabolism of thalidomide by h ...... ngiogenic activities in vitro.
@nl
P2093
P2860
P356
P1476
Metabolism of thalidomide by h ...... ngiogenic activities in vitro.
@en
P2093
P2860
P356
10.1002/HON.992
P577
2011-06-03T00:00:00Z